Skip to main content

Molecular Defects in Cardiovascular Disease

  • Book
  • © 2011

Overview

  • Outlines novel targets for the treatment of cardiovascular diseases

  • Elucidates the role of biochemical insults and metabolic derangements in altering gene expression

  • Provides an understanding of the molecular genesis of cardiovascular dysfunction

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (27 chapters)

  1. Molecular Mechanisms in Heart Disease

  2. Cardiac Hypertrophy and Heart Failure

  3. Cardiac Hypertophy and Heart Failure

Keywords

About this book

Molecular Defects in Cardiovascular Disease provides an in-depth discussion of the molecular mechanisms underlying the genesis of cardiovascular defects and the implications this has on current and emerging targeted therapeutics.  Divided into three sections, this book covers the scientific foundations of our present understanding as well as the array of clinical manifestations and their treatment.  The first section covers Molecular Mechanisms of Heart Disease, with discussion of the development of cardiovascular dysfunction.  The remaining two sections provide a more clinical focus.  The second, Cardiac Hypertrophy and Heart Failure deals with metabolic derangements, Ca2+ handling, and subcellular remodeling.  It illustrates the wide variety of molecular defects which may serve as targets associated with the transition from cardiac hypertrophy to advanced heart failure.  The third section, Hypertension and Diabetes, provides molecular rationale for the pathogenesis of hypertension and diabetic cardiomyopathy, as well as highlighting the importance of hormones toward this end. 

A necessary resource for clinicians and researchers, this book elucidates the experimental basis of the practice of cardiology.  It is the culmination of our advances in the understanding of cardiovascular molecular biology and a blueprint for the efficacious use of targeted therapies.

Editors and Affiliations

  • St. Boniface General Hospital, Research Centre, Institute of Cardiovascular Sciences, Winnipeg, Canada

    Naranjan S. Dhalla

  • Jikei University School of Medicine, Tokyo, Japan

    Makoto Nagano

  • Czech Republic, Institute of Physiology, Academy of Sciences of the, Prague, Czech Republic

    Bohuslav Ostadal

Bibliographic Information

  • Book Title: Molecular Defects in Cardiovascular Disease

  • Editors: Naranjan S. Dhalla, Makoto Nagano, Bohuslav Ostadal

  • DOI: https://doi.org/10.1007/978-1-4419-7130-2

  • Publisher: Springer New York, NY

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2011

  • Hardcover ISBN: 978-1-4419-7129-6Published: 09 August 2011

  • Softcover ISBN: 978-1-4939-4115-5Published: 23 August 2016

  • eBook ISBN: 978-1-4419-7130-2Published: 09 August 2011

  • Edition Number: 1

  • Number of Pages: XVIII, 382

  • Number of Illustrations: 47 b/w illustrations, 31 illustrations in colour

  • Topics: Cardiology, Medical Biochemistry

Publish with us